https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-replimune-cutting-jobs-as-fda-rejects-rp1-a-second-time-R7NN6KDVMVB65EL2YQQVSNVLJA/2026-04-10T22:25:20.046Zalways0.5https://insights.citeline.com/resizer/lX8-Vs0-l2lH5ZQHnromxpP0muA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/7NTRUR6TDRO5XBZ2AHBDBYLEDM.jpghttps://insights.citeline.com/scrip/top-12-pharma-companies-eli-lilly-shoots-to-the-top-merck-tumbles-WCGHYLQW45D4BKOEYZXBI6WAQI/2026-04-10T22:24:14.476Zalways0.5https://insights.citeline.com/resizer/FZegzOb2w3OlcekdPlbloRT_wLM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ULSX6MQFA5NG7NA6MKSSQHX4JY.jpghttps://insights.citeline.com/scrip/r-and-d/pipeline-watch/pipeline-watch-three-approvals-and-thirteen-phase-iii-readouts-H2ZZDR5GA5G75LRBNTFXTA4JD4/2026-04-10T22:22:53.156Zalways0.5https://insights.citeline.com/resizer/mwgLSJZ0a5U0mjF6EXfMd2TDtec=/cloudfront-us-east-1.images.arcpublishing.com/norstella/R4HJYLHCRZMUHILQHESB7CGVPA.jpghttps://insights.citeline.com/medtech-insight/business/r-and-d/clinical-trials/umsom-researcher-to-drive-innovation-by-making-new-cervix-organ-on-a-chip-widely-accessible-KVWNBZM625FDTGFCXXNY7H57XU/2026-04-10T22:14:37.072Zalways0.5https://insights.citeline.com/resizer/npqTciVwzRV6IOUQXu4Cg9VW3jo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4SRSRV5MBBHQDEZ3PU33JOJPR4.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/compliance/guidance/global-medtech-guidance-tracker-march-2026-YYEI5CO2CREGPNEOPGHVMURSYA/2026-04-10T22:05:01.927Zalways0.5https://insights.citeline.com/resizer/hk6fQmOyLH0jxshmvw0nTFYaNEs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QHVTXFRQGJMONJWKOOOUUUQVJE.jpghttps://insights.citeline.com/scrip/business/financing/biopharma-ipos-had-their-best-showing-in-more-than-a-year-in-q1-RH3FIPOD4BFDBLAL2KAII4E76E/2026-04-10T22:02:48.863Zalways0.5https://insights.citeline.com/resizer/CaILZIu0bE9YYVH12F5FEzAdZlA=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RSDRD52ECZCTPGR7WAEAU3HGEE.jpghttps://insights.citeline.com/medtech-insight/digital-technologies/fda-challenges-innovators-to-help-reduce-hospital-readmissions-by-advancing-at-home-care-7RH7X46ATFHDVJMV2EYPMIVMOM/2026-04-10T21:37:22.715Zalways0.5https://insights.citeline.com/resizer/jwR2HQWHXmAiDq3dS8jInVy2HZs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HFKOQZQF4FHGBHGT3VHQ4QC5YE.jpghttps://insights.citeline.com/medtech-insight/business/deals/boehringer-hands-ct-155-commercial-rights-to-click-therapeutics-in-50m-deal-restructure-GVU4Q75IX5FNFJ7K6MWQQDB6EY/2026-04-10T21:35:46.594Zalways0.5https://insights.citeline.com/resizer/6xFv8GXLANA1fvfNvkhbFA636mU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UIZSPXQVC5CB5CD5YPJOEALEOI.jpghttps://insights.citeline.com/medtech-insight/policy-and-regulation/recalls/medline-recalls-millions-of-angiographic-syringes-after-fda-warning-letter-GI7XZ63VIJGZRNEKFEIHBNUMPQ/2026-04-10T18:48:54.163Zalways0.5https://insights.citeline.com/resizer/RwbkliyT07W6vpz4F3Gt1FgzyrI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SZV5OZXDNBA6RFWIKJG4P3FIAY.jpghttps://insights.citeline.com/medtech-insight/device-area/diagnostics/singapores-asian-population-cohort-dataset-to-move-forward-with-seers-proteograph-platform-I2SSZMVHYRGU5JHXJYBKKNZPUM/2026-04-10T16:06:15.75Zalways0.5https://insights.citeline.com/resizer/Qgh4zErgtQdeWz1BfK6rcGnYamY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JRNRYW5ZLZCWXHZRADM66MB6MY.jpghttps://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/dietary-substance-for-use-by-man-to-supplement-the-diet-open-or-closed-door-for-innovation-3CLUJQ6GQFAPPK2KDV3XWW7AWY/2026-04-10T15:51:51.446Zalways0.5https://insights.citeline.com/resizer/pFTuDXtZ3a2s0UbFSka0IM7PseM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/CPG2S5V5KZD4PDQN2AUBAWKCSU.jpghttps://insights.citeline.com/generics-bulletin/business/deals/organon-rumors-persist-despite-suns-fresh-denial-YMGTFOZ4RNGNZHT6KEPR3TUMF4/2026-04-10T15:39:20.013Zalways0.5https://insights.citeline.com/resizer/pLdIf0JR42slRCDxAShi4HQIO6c=/cloudfront-us-east-1.images.arcpublishing.com/norstella/47HS3VEUVJMA5ASJWIWYXTSR2Q.jpghttps://insights.citeline.com/pink-sheet/regulatory-trackers/global-pharma-guidance-update/global-pharma-guidance-tracker-march-2026-EVHY43JLLJBJ5H45ZPLJTZXAX4/2026-04-10T15:27:16.808Zalways0.5https://insights.citeline.com/resizer/pyXNgDhSsN63aHmz5GtethgJs6Y=/cloudfront-us-east-1.images.arcpublishing.com/norstella/J47YR4CKUVM3VELDJJRV4RSQ4A.jpghttps://insights.citeline.com/scrip/business/deals/roche-and-c4-expand-alliance-into-degrader-antibody-conjugate-work-JO5FLJPGYJCZPLEITAT5TLPYO4/2026-04-10T15:02:37.383Zalways0.5https://insights.citeline.com/resizer/S33uev2p8EatfV9QUT9ATFIhplY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IUICLMRRL5FCDHAL26CO2QYMTM.jpghttps://insights.citeline.com/scrip/business/financing/venture-funding-keeps-a-steady-pace-in-q1-YCRVNSKYFBHKJMBV5U5Y3S5QMQ/2026-04-10T14:01:48.682Zalways0.5https://insights.citeline.com/resizer/-MvP7RFMhU673w3_Npj1Y3atduk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/Y5HEYZ3PA5DHFJPHH3KTX3QSWM.jpghttps://insights.citeline.com/scrip/business/deals/march-surge-lifts-first-quarter-ma-totals-to-recent-highs-BUBMWUXFVZA4XJNGDUBLZ6OKEE/2026-04-10T14:00:06.855Zalways0.5https://insights.citeline.com/resizer/y7HxBuYHp2L0a79teHlGTljCl6o=/cloudfront-us-east-1.images.arcpublishing.com/norstella/VTST32GRCJHMXM73OJSD2F4KYE.jpghttps://insights.citeline.com/pink-sheet/policy-regulation/us-pharma-tariffs-exemptions-need-more-clarity-impact-varied-EJDAKYPZYNHA7FPUAYAYF3COJU/2026-04-10T11:35:21.134Zalways0.5https://insights.citeline.com/resizer/PvehnlJJAt1Q1w45VwWF_DTVdWw=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ND5GEZFMFBHPPOYWL7A2UDQ7DA.jpghttps://insights.citeline.com/generics-bulletin/policy-and-regulation/regulation/us-fda/outlook-goes-after-fda-with-formal-dispute-resolution-request-25AKCQHFONAKTEI5KRJJZD52PQ/2026-04-10T10:47:56.247Zalways0.5https://insights.citeline.com/resizer/RqWmzFlTNAiWxSWXukuP47kXDLE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/PTNNGXNNHNFMZJME6GNFNFTG34.jpghttps://insights.citeline.com/scrip/iran-war-indias-supply-chain-shocks-contract-stress-and-spillover-risks-M7A2H6KTIZAW5MIV2YAF3AWQIQ/2026-04-10T10:36:22.53Zalways0.5https://insights.citeline.com/resizer/8joRpBnp4uYSFB73KUtJETw0C28=/cloudfront-us-east-1.images.arcpublishing.com/norstella/YVA3TROSBFCRRLECVFM6YUZ73Y.jpghttps://insights.citeline.com/generics-bulletin/leadership/interviews/the-number-one-priority-is-sustainable-access-aam-chair-hoffman-on-stabilizing-the-us-industry-3MSBKUFTMVCUHIPT5NYGEOQKWU/2026-04-10T10:31:42.526Zalways0.5https://insights.citeline.com/resizer/nTV5gv8DQIIhcCBB2isc2phfet8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/OVUE345GRFAJPA4TAGZCG2OWT4.jpghttps://insights.citeline.com/generics-bulletin/business/deals/gtcr-takeover-fuels-zentiva-expansion-across-european-markets-3IULVACJHJBPRBLBNT6CA4CVRQ/2026-04-10T10:31:27.358Zalways0.5https://insights.citeline.com/resizer/s0fPTZ77ElijvCYakTLkICHFApI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ARY4XMN4WJMEBFGFH2ECTVEI5I.jpghttps://insights.citeline.com/scrip/therapeutic-category/anticancer/macrogenics-avoids-worst-case-scenario-for-lorigerlimab-as-us-fda-lifts-trial-hold-6INNQTNCDBGLRBUWIX5TGVS73Q/2026-04-10T08:40:25.684Zalways0.5https://insights.citeline.com/resizer/me-0mlm97jiLv3Lnb37NCRxoKGU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/FRDEFJ2G3ZB3DEPZKT2UOOQPR4.jpghttps://insights.citeline.com/scrip/focus-on-asia/japan/sumitomo-to-fortify-rd-pay-off-debt-through-730m-stock-offering-D2QYYDXGAVFWJN26KAK2XQYM3M/2026-04-10T07:01:11.325Zalways0.5https://insights.citeline.com/resizer/5oPwthppYTJCQ5gNNJWqoRsi3No=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JHMFEPLZTBCZRNLDVSVIRZ27RI.jpghttps://insights.citeline.com/medtech-insight/device-area/cardiology/no-new-hardware-required-bds-hemosphere-stream-to-bring-continuous-bp-monitoring-to-any-bedside-QONU3XSYWRGF7GVU6YGS2T43KE/2026-04-10T06:55:42.344Zalways0.5https://insights.citeline.com/resizer/hTBMQXiwv1b3e4a6BtTBpNQWjZ4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XT4J3MHU5FBJPIBJLOCAN4YXLM.jpghttps://insights.citeline.com/pink-sheet/advanced-technologies/ai/china-launches-nationwide-plan-for-ai-assisted-drug-regulation-BARVROXCQFC2HBUOQFCKUF3F5A/2026-04-10T06:26:34.79Zalways0.5https://insights.citeline.com/resizer/04IKv6RcLoWaGDL0B7vUHJ4FdJ0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XPQNR3ASZBERZHBZZD6RMLGJ6E.jpghttps://insights.citeline.com/pink-sheet/compliance/distribution-supply-chain/korea-on-alert-for-medical-product-shortages-amid-middle-east-crisis-AM7JU6RK2BCIDDMVXFUQNE7KNY/2026-04-10T04:49:29.873Zalways0.5https://insights.citeline.com/resizer/YfyeCw37wc4WYcs38Ug8dZed0NY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/NN3DHTQZRBCLDLNGZXVQ7PAFTY.jpghttps://insights.citeline.com/scrip/drug-pricing/us-100-tariffs-loom-over-approved-chinese-innovative-drugs-GNLDG2227JCTLNCJGTZCPWXZQY/2026-04-10T00:11:38.231Zalways0.5https://insights.citeline.com/resizer/FknOHA5wX_kn9aCiLfQI2SoRG7w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ACL6F7AJ6BDBPJA2C42HVJI3YM.jpghttps://insights.citeline.com/companies/renovare-therapeutics2026-04-10T00:09:35.639Zalways0.5https://insights.citeline.com/companies/plateletdiagnostics-llc2026-04-10T00:09:33.549Zalways0.5https://insights.citeline.com/companies/garda-therapeutics2026-04-10T00:09:29.637Zalways0.5https://insights.citeline.com/companies/synexa-life-sciences2026-04-10T00:09:25.601Zalways0.5https://insights.citeline.com/companies/national-cerebral-and-cardiovascular-center2026-04-10T00:09:21.482Zalways0.5https://insights.citeline.com/companies/applied-food-sciences-inc2026-04-10T00:09:17.636Zalways0.5https://insights.citeline.com/companies/shanghai-qingrun-pharmaceutical-technology-co-ltd2026-04-10T00:09:13.392Zalways0.5https://insights.citeline.com/companies/hesperos-inc2026-04-10T00:09:09.378Zalways0.5https://insights.citeline.com/companies/ahead-therapeutics-sl2026-04-10T00:09:05.627Zalways0.5https://insights.citeline.com/companies/beijing-demo-hi-tech-pharmaceutical-technology-co-ltd2026-04-10T00:09:01.308Zalways0.5https://insights.citeline.com/companies/first-tracks-biotherapeutics-inc2026-04-10T00:08:57.374Zalways0.5https://insights.citeline.com/companies/sai-life-sciences2026-04-10T00:08:53.168Zalways0.5https://insights.citeline.com/companies/hasten-biopharmaceuticals-sg-pte-ltd2026-04-10T00:08:45.185Zalways0.5https://insights.citeline.com/companies/shanghai-record-pharmaceuticals-co-ltd2026-04-10T00:08:41.13Zalways0.5https://insights.citeline.com/companies/cegat-gmbh2026-04-10T00:08:37.054Zalways0.5https://insights.citeline.com/companies/unc-lineberger2026-04-10T00:08:29.168Zalways0.5https://insights.citeline.com/companies/nanjing-chia-tai-tianqing-pharmaceutical-co-ltd2026-04-10T00:08:25.041Zalways0.5https://insights.citeline.com/companies/opal-biosciences2026-04-10T00:08:20.002Zalways0.5https://insights.citeline.com/companies/inquis-medical2026-04-10T00:08:13.914Zalways0.5https://insights.citeline.com/companies/chengdu-vincentage-pharmaceutical-technology-co-ltd2026-04-10T00:08:07.986Zalways0.5https://insights.citeline.com/companies/rheumagen-inc2026-04-10T00:08:02.003Zalways0.5https://insights.citeline.com/companies/inatherys2026-04-10T00:07:55.919Zalways0.5https://insights.citeline.com/companies/bora-pharmaceuticals2026-04-10T00:07:49.915Zalways0.5https://insights.citeline.com/companies/gynica2026-04-10T00:07:43.76Zalways0.5https://insights.citeline.com/companies/oncox-biopharma-inc2026-04-10T00:07:37.89Zalways0.5https://insights.citeline.com/companies/sathgen-therapeutics2026-04-10T00:07:31.678Zalways0.5https://insights.citeline.com/companies/eikonizo-therapeutics2026-04-10T00:07:25.668Zalways0.5https://insights.citeline.com/companies/innovative-molecules-gmbh2026-04-10T00:07:20.048Zalways0.5https://insights.citeline.com/companies/oncoverity-inc2026-04-10T00:07:13.784Zalways0.5https://insights.citeline.com/companies/okogen-inc2026-04-10T00:07:07.778Zalways0.5https://insights.citeline.com/companies/ns-pharma-inc2026-04-10T00:07:01.619Zalways0.5https://insights.citeline.com/companies/innova-vascular-inc2026-04-10T00:06:55.78Zalways0.5https://insights.citeline.com/companies/meihua-international-medical-technologies-co-ltd2026-04-10T00:06:49.787Zalways0.5https://insights.citeline.com/companies/fascinate-therapeutics-inc2026-04-10T00:06:43.545Zalways0.5https://insights.citeline.com/companies/revir-therapeutics2026-04-10T00:06:37.482Zalways0.5https://insights.citeline.com/companies/nuvectis-pharma-inc2026-04-10T00:06:31.398Zalways0.5https://insights.citeline.com/companies/greywolf-therapeutics-ltd2026-04-10T00:06:25.43Zalways0.5https://insights.citeline.com/companies/reset-pharmaceuticals-inc2026-04-10T00:06:19.514Zalways0.5https://insights.citeline.com/companies/oncoqr-ml-gmbh2026-04-10T00:06:13.398Zalways0.5https://insights.citeline.com/companies/oncomatryx-biopharma-sl2026-04-10T00:06:07.593Zalways0.5https://insights.citeline.com/companies/gpcr-therapeutics-inc2026-04-10T00:06:01.401Zalways0.5https://insights.citeline.com/companies/medac-pharma-production-gmbh2026-04-10T00:05:55.313Zalways0.5https://insights.citeline.com/companies/dewpoint-therapeutics2026-04-10T00:05:49.328Zalways0.5https://insights.citeline.com/companies/banner-alzheimers-institute2026-04-10T00:05:43.289Zalways0.5https://insights.citeline.com/companies/tsrl-inc2026-04-10T00:05:37.739Zalways0.5https://insights.citeline.com/companies/life-biosciences-llc2026-04-10T00:05:31.26Zalways0.5https://insights.citeline.com/companies/mead-johnson-nutrition-co2026-04-10T00:05:25.137Zalways0.5https://insights.citeline.com/companies/ache-laboratorios-farmaceuticos-sa2026-04-10T00:05:18.973Zalways0.5https://insights.citeline.com/companies/imvax-inc2026-04-10T00:05:13.057Zalways0.5https://insights.citeline.com/companies/cyclarity-therapeutics-inc2026-04-10T00:05:07.147Zalways0.5https://insights.citeline.com/companies/soleno-therapeutics-inc2026-04-10T00:05:01.14Zalways0.5https://insights.citeline.com/companies/washington-university-school-of-medicine2026-04-10T00:04:54.871Zalways0.5https://insights.citeline.com/companies/creo-medical-ltd2026-04-10T00:04:49.186Zalways0.5https://insights.citeline.com/companies/sydney-childrens-hospitals-network2026-04-10T00:04:43.002Zalways0.5https://insights.citeline.com/companies/shandong-buchang-pharmaceuticals-co-ltd2026-04-10T00:04:36.821Zalways0.5https://insights.citeline.com/companies/gl-pharmtech2026-04-10T00:04:30.799Zalways0.5https://insights.citeline.com/companies/recipharm-ab2026-04-10T00:04:24.915Zalways0.5https://insights.citeline.com/companies/national-center-of-neurology-and-psychiatry2026-04-10T00:04:18.778Zalways0.5https://insights.citeline.com/companies/ifm-therapeutics2026-04-10T00:04:13.039Zalways0.5https://insights.citeline.com/companies/hummingbird-bioscience2026-04-10T00:04:06.643Zalways0.5https://insights.citeline.com/companies/c4-therapeutics-inc2026-04-10T00:04:00.836Zalways0.5https://insights.citeline.com/companies/huadong-medicine-coltd2026-04-10T00:03:54.653Zalways0.5https://insights.citeline.com/companies/imaginab-inc2026-04-10T00:03:48.691Zalways0.5https://insights.citeline.com/companies/ideaya-biosciences-inc2026-04-10T00:03:42.709Zalways0.5https://insights.citeline.com/companies/everest-medicines-limited2026-04-10T00:03:36.655Zalways0.5https://insights.citeline.com/companies/imunon-inc2026-04-10T00:03:30.515Zalways0.5https://insights.citeline.com/companies/gilead-sciences-inc2026-04-10T00:03:27.398Zalways0.5https://insights.citeline.com/companies/jupiter-neurosciences-inc2026-04-10T00:03:24.442Zalways0.5https://insights.citeline.com/companies/trevi-therapeutics-inc2026-04-10T00:03:15.485Zalways0.5https://insights.citeline.com/companies/irhythm-technologies-inc2026-04-10T00:03:03.477Zalways0.5https://insights.citeline.com/companies/nippon-shinyaku-co-ltd2026-04-10T00:02:51.494Zalways0.5https://insights.citeline.com/companies/dupont-de-nemours-and-company2026-04-10T00:02:39.489Zalways0.5https://insights.citeline.com/companies/proqr-therapeutics-nv2026-04-10T00:02:27.51Zalways0.5https://insights.citeline.com/companies/merck-co-inc2026-04-10T00:02:03.277Zalways0.5https://insights.citeline.com/companies/paion-ag2026-04-10T00:01:51.17Zalways0.5https://insights.citeline.com/companies/kite-pharma-inc2026-04-10T00:00:57.202Zalways0.5https://insights.citeline.com/companies/neurocrine-biosciences-inc2026-04-10T00:00:45.22Zalways0.5https://insights.citeline.com/companies/insmed-incorporated2026-04-10T00:00:33.21Zalways0.5